Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa
about
Mesulergine in early Parkinson's disease: a double blind controlled trialHypertensive crisis in a patient given sinemet, metoclopramide, and amitriptylineThe alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's diseaseThe Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.The use of dopamine agonists in very elderly patients with Parkinson's disease.Bromocriptine in Parkinson's disease: a study of cardiovascular effects
P2860
Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa
description
1976 nî lūn-bûn
@nan
1976 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
Bromocriptine in Parkinsonism: ...... , and comparison with levodopa
@ast
Bromocriptine in Parkinsonism: ...... , and comparison with levodopa
@en
type
label
Bromocriptine in Parkinsonism: ...... , and comparison with levodopa
@ast
Bromocriptine in Parkinsonism: ...... , and comparison with levodopa
@en
prefLabel
Bromocriptine in Parkinsonism: ...... , and comparison with levodopa
@ast
Bromocriptine in Parkinsonism: ...... , and comparison with levodopa
@en
P2860
P356
P1476
Bromocriptine in Parkinsonism: ...... , and comparison with levodopa
@en
P2093
P2860
P304
P356
10.1136/JNNP.39.11.1101
P407
P577
1976-11-01T00:00:00Z